Thirty-nine infants with simple vitamin D deficiency were studied; three stages of deficiency were recognized. Stage I comprised hypocalcemia, usually as the sole important biochemical finding, while convulsions were a common clinical sign. Stage I1 revealed normocalcemia with hyperaminoaciduria, hypophosphatemia, and hyperphosphaturia; rickets was also in evidence. Stage I11 was comparable to stage 11, but with recurrence of hypocalcemia and convulsions, the rickets was more severe. Patients progressed spontaneously from the early to the later stages of the deficiency syndrome; administration of parathyroid extract appeared to accelerate the rate of progression. Calcium infusion and vitamin D therapy each initially raised the serum calcium level in hypocalcemic patients; thereafter, aminoaciduria and hyperphosphaturia were suppressed.
Introduction
Circumstances still exist in Canada which predispose to vitamin D deficiency in the human infant. Vitamin D supplementation of bottled dairy milk is uncommon in this country, and during the winter months infants acquire little vitamin D from exposure to sunlight.
Since fluid milk constitutes the principal nutrient of infants in the poorer urban populations, it is not surprising, therefore, that many cases of vitamin D deficiency still occur in the spring months among infants born in the previous year.
Vitamin D deficiency can present with a wide variety of manifestations [23] . Among these, the abnormalities of urinary excretion involving phosphorus [l, 23, 281 , amino acids [19, 25, 271 and bicarbonate [47, 481 have long been of interest to investigators. Hyperaminoaciduria has been recognized as a component of the human vitamin D deficiency syndrome for over 30 years [6, 8, 12, 19, 25, 27, 45] ; thisphenomenon which occurs in some, but not in all infants with vitamin D deficiency [8, 19, 25, 45] attracted our particular attention. Thirty-nine untreated patients were studied and correlations made of biochemical, clinical and radiographic information. On the basis of the observations to be reported, we propose that the human vitamin D deficiency syndrome develops progressively in three 'stages': an early stage with hypocalcemia and minimal bone demineralization; an intermediate stage with normocalcemia, hypophosphatemia, hyperaminoaciduria and moderate rickets; and a later stage with -hypophosphatemia, hyperaminoaciduria, reappearance of hypocalcemia and advanced rickets. We suggest these three stages reflect progressive vitamin D depletion, modified by resultant hyperparathyroidism, the latter being the factor which impairs renal tubular function.
Materials and Methods

Patients
Thirty-nine infants were investigated. The criteria for acceptance of a patient into the study were: 1. that all investigations were performed at admission on the same day 2. that no therapy (vitamin D or calcium) had been given prior to the investigations 3. that rapid healing of rickets occurred subsequently on a therapeutic dosage of vitamin D, (5000 units/day x 4 weeks) and without recurrence of rickets when the normal daily requirement (400 IU/day) was instituted thereafter.
Determinations of total calcium, inorganic phosphorus and alkaline phosphatase were made on serum or plasma taken in the morning before feeding; the amino acid content of urine was measured, and roentgenograms of skull and long bones were obtained. The X-ray films were evaluated by one radiologist1 without foreknowledge of the patient's biochemical and clinical status.
Analytical Methods
Calcium was determined by a titrimetric method [9] , inorganic phosphorus by the molybdate method [17] , and alkaline phosphatase activity by the method of KING and ARMSTRONG [30] .
Urine samples were obtained by spontaneous voiding and the amino acid content assessed by ascending two-dimensional partition chromatography [13] . An aliquot equivalent to 250 pg total nitrogen was chromatographed on 10-inch square Whatman No.4 filter paper. The chromatogram was first developed in an ammonia atmosphere with water-saturated phenol solvent (Mallinckrodt), which was then dried off overnight at 25". The second solvent was 2,6-lutidine (95 % Practical-Eastman Organic Chemicals) : water (2.2 : 1). After drying overnight, the chromatogram was dipped in a mixture of ninhydrin (0.25 % w/v), isatin (0.01 % w/v), 2,6-lutidine (1 % v/v), in acetone2, and heated at 80' for ten minutes. The chromatograms were viewed by transmitted light. The intensity of each spot was evaluated visually on an arbitrary scale (0-10 units) and the degree of aminoaciduria expressed as the arithmetic sum of the spot 'values'. The ratings were made by two observers reading independently, and the average of the two totals was used. The reliability of the visual scoring method was evaluated by comparing the summed 'spot units' with a quantitative measurement of total aminoaciduria. Urine samples from nine normal children and from four patients with vitamin D deficiency were analyzed on ground ion exchange resin columns using a Beckman Spinco Model-120 amino acid analyzer [42. ] A linear relation between the two methods of estimating the aminoaciduria was observed -( fig. 1 ) in the range encountered with the majority of samples in the study.
Endogenous amino acid clearance rates were measured quantitatively using elution chromatography on ion exchange resin columns as described previously [sol.
Special procedures were done on additional patients (Part 11). Prolonged intravenous infusion of calcium was performed using the technique described by FRASER et al. [18] . Inorganic phosphorus was infused intraDr. J.S.DUNBAR, Radiologist-in-Chief, Montreal Children's Hospital. SHAW, K. N. F. : personal communication.
Hyperparathyroidism as the cause of hyperaminoaciduria a n d phosphaturia in h u m a n . . . 427 venously in a buffered solution as described earlier 60 [40] . Parathyroid extract3 (PTE) was given subcutaneously in rotated sites. Blood samples in these special 5 studies were always obtained in the fasting state in the 5 45 morning to minimize the effect of diurnal and dietary F variation; all serum calcium values were corrected to @ a standard specific gravity of 1.027 [14] . Figure 2A indicates the relation of the initial calcium value to the urinary amino acid excretion; figure 2 B shows the relation of initial phosphorus value to urinary amino acid excretion in the same patients. The shaded area in each figure represents the normal range for aminoaciduria and for serum calcium or serum phosphorus. For purposes of discussion of the results, each graph is divided into four areas by a horizontal line, which arbitrarily differentiates normal from hypocalcemia at 9.0 mgl 100 ml and normal from hypophosphatemia at 4.0 mg/ 100 ml; and by a vertical line, which differentiates normal from hyperaminoaciduria at 15 units. The latter value was derived from a review of chromatograms obtained from the normal children ( fig. 1 ).
Three groups of patients with the vitamin D deficiency syndrome are evident in figure 2; additional information on these patients is summarized in table I and as follows :
Group I
There were nine patients (solid circles, fig.2 ), in whom the serum calcium was less than 9.0 mgJ100 ml, and in whom the serum phosphorus level was normal. Of these, six had normal aminoaciduria, and in only three was minimal hyperaminoaciduria found. In six patients, the radiological signs (solid circles, fig. 3 ) were confined to a loss of definition of skull sutures and some demineralization of the calvarium; this was a characteristic roentgen sign of this stage of vitamin D deficiency; in the three other patients, mild rickety changes in long bones were also seen.
Six patients presented with convulsions and one with tetany; in none was vitamin D deficiency the initial diagnosis. The age on admission ranged from 2-12 months, with the peak at 4-6 months.
Para-Thor-Mone, Lilly. Group I I There were 13 patients in this group (open circles, fig.2 ). In all, the serum calcium level was norma1 (> 9.0 mg/100 ml), the phosphorus level was below 4.0 mp/100 ml, and there was hyperaminoaciduria. All patients had typical radiological signs of moderate fig. 3 ). In only two patients was the diagnosis of rickets made purely on clinical signs and the history; in half of the patients, the admitting diagnosis was 'bronchopneumonia'. The age on admission ranged from 4-1 3 months, with a peak incidence between 6-8 months.
Grout 111
Seventeen patients had hypocalcemia, hypophosphatemia and hyperaminoaciduria (crosses, fig. 2 ). Roentgen signs of rickets were florid and unmistakable in most patients (crosses, fig. 3 ). In four patients, roentgen signs of hpyerparathyroidism were found in long bones, phalanges or clavicles; these signs included subperiosteal erosion in phalanges and long bones and the 'rotting stump' sign in clavicles and ulna.
These infants exhibited the classical clinical signs of rickets and were diagnosed clinically. Three infants were admitted with convulsions. The age range was 4--40 months, with the peak between 6-12 months. 
Results
Mechanism of the Hyperaminoaciduria
The endogenous renal clearance rates of amino acids were measured in the fasting stage in one patient Hyperparathyroidism as the cause of hypera .minoaciduria and phosphaturia i n human.. . 429 with stage I1 deficiency, and in another with stage I11 deficiency. The renal clearance rates of most amino acids were significantly elevated in the presence of normal ~l a s m a concentrations of the affected amino acids (table 11) . The h~~eraminoaciduria of vitamin D deficiency is generalized and is the result of impaired tubular conservation. These data confirm the work of earlier investigators [6, 12, 
Correlation of Aminoaciduria with Phosphaturia
The hypophosphatemia of human vitamin D deficiency is related to its high renal clearance [23, 281 . Inhibition of tubular absorption of phosphate, either by deficiency of vitamin D or by endogenous parathyroid hormone, has been proposed to account for this phenomenon [8, 21, 23, 431 . If the inhibition of tubular transport of phosphate and amino acids in patients with the vitamin D deficiency snydrome has a common antecedent [8] , then a direct relation between the excretion rates of phosphorus and amino acids might be anticipated. The inverse relation between blood phosphorus and hyperaminoaciduria, which has been observed here ( fig. 2 B) , and by others [8] , would, in this case, also be anticipated.
A direct relation (r = 0.72) between hyperaminoaciduria and hyperphosphaturia was observed ( fig. 4 ) in nineteen patients with various stages of the deficiency syndrome in whom the phosphorus and amino acid content of urine was measured in the same urine sample.
Sflontaneous Evolution of the Vitamin D Deficiency Syndrome
Five infants with vitamin D deficiency were placed immediately at the time of diagnosis on a diet containing unenriched dairy milk; no vitamin D supplement was given. Four of these patients had hypocalcemia and were classified as stage I (early) deficiency. In each patient, the serum calcium rose slowly and spontaneously (fig. 5A) ; this was accompanied by an increase in the aminoaciduria and a decrease in the serum phosphorus level ( fig.5B) . One of these patients also exhibited progression in roentgen signs over a thirteenday period of observation ( fig.3 ). In effect, the four patients progressed spontaneously from stage I to stage I1 of the deficiency syndrome.
A fifth patient ( fig. 5 ) was initially classified as stage I1 deficiency on the basis of biochemical and roentgen findings. In the subsequent six days the serum calcium level fell, and the aminoaciduria increased; his serum phosphorus level remained below normal. These findings suggest a progression of the deficiency syndrome to stage 111. Response to Exogenous Parathyroid Hormone Parathyroid extract was given intramuscularly (50 USP units, q 6 h x 4 days) to six untreated patients ( fig. 6 ). Sufficient dosage of exogenous hormone might accelerate the transition from the existing to the next stage of the deficiency syndrome, if this transition is parathyroid dependent.
Three patients with stage I deficiency responded rapidly to PTE with increased serum calcium levels and augmented aminoaciduria; plasma phosphorus fell in two of the subjects (fig. 6 ). The response occurred more rapidly than in untreated patients ( fig.5 ), suggesting that comparable changes might not have occurred during the elapsed time, in the absence of the exogenous hormone. The sequential response in time of one patient with stage I deficiency, before, during and after PTE, and then with vitamin D, treatment, is presented in table 111. Upon withdrawal of PTE, there is a reversion to pretreatment status.
Two patients with stage I1 deficiency, one of whom showed some spontaneous progression prior to injection, were also given PTE. This procedure raised the serum calcium, and aminoaciduria declined slightly during the period of calcium elevation. The existing low serum phosphorus levels did not change greatly.
In one patient with presumed stage I11 deficiency, the same dose of parathyroid extract used in the other patients failed to increase to serum calcium level to the normal range; on the other hand, the hypophosphatemia was exaggerated and the aminoaciduria increased further.
Resbonse to Intravenous Calcium Infusion
Two vitamin D-deficient patients were infused with calcium. In one patient with stage I deficiency (J.A., table IV), the infusion produced unequivocal hypercalcemia; when this had been sustained for approximately six hours, the hyperaminoaciduria began to decline. Net tubular reabsorption of amino acids had increased greatly in the seventh, eighth and ninth hours of the infusion; complete phosphate reabsorption was achieved at the same time ( fig. 7 ). In the second patient (F.B., table IV) with stage I11 deficiency, the infusion achieved only a normal serum calcium level, a finding in keeping with the more severe bone changes [lo] . Renal clearance of amino acids was, however, reduced by this procedure, although net tubular absorption of amino acids was less improved because of an apparent fall in glomerular filtration rate during the procedure. Calcium infusion did not appreciably alter amino acid absorption and excretion in four control patients, each affected with one variety of the Fanconi syndrome.
Phosfihorus Infusion
Many workers have proposed an association between phosphorus and amino acid transport [4, 8, 161 ; some have suggested that the defect in phosphorus metabolism might, in itself, influence tubular absorption of amino acids [8] . One of our patients with type I1 deficiency was given a phosphorus infusion. The serum phosphorus level rose from 2.8 to 6.1 mg/100 ml, while the serum calcium level fell from 8.6 to 6.1 mg/100 ml. The filtered load of amino acids did not change significantly (preinfusion, 233.4 pmoles/min/l.73 m2; infusion, 226.12 pmoles/min/l.73 m2), whereas the reabsorbed fraction dropped from 94 % to 87.7 % during the infusion.
Resfionse to Vitamin D Therapy
If hyperparathyroidism accounts for the aminoaciduria and phosphaturia of vitamin D deficiency, treatment with vitamin D shouldjrst enhance calcium homeostasis, thereby suppressing the hyperparathyroidism; then the h~peraminoaciduria and hypophosphatemia should return to normal. We followed the response to vitamin D therapy in patients with the deficiency syndrome ( fig. 8) . In two patients, serum cal- cium levels rose immediately, clearly preceding any improvement in plasma phosphorus levels and in amino acid excretion. In no patient with prior hypocalcemia did the serum phosphorus level or amino acid excretion improve without a concomitant improvement in the serum calcium level.
Discussion
Vitamin D deficiency in the human infant can be divided into three stages on the basis of the clinical data obtained in the present study (part I). We propose that endogenous hyperparathyroidism, in response to the primary effect of vitamin D deficiency upon calcium metabolism, accounts for the biochemical and clinical findings peculiar to the three stages of vitamin D deficiency (Part 11). Although the evidence for significant hyperparathyroidism in human vitamin D deficiency is circumstantial [5, 10, 21, 23, 26, 28, 34, 43, 451, it is quite convincing and can be summarized as follows: 1. The level of serum calcium during the three stages of deficiency ( fig. 2, table I ), varies in accordance with the predicted relation between PTH and vitamin D [2, 381 and their respective roles in the intestinal absorption of calcium and its release from bone. 2. Urinary excretion of phosphorus varies in direct proportion to the aminoaciduria in human vitamin D deficiency (fig. 4) ; plasma phosphorus levels and aminoaciduria ( fig. 2 B) vary inversely [8] . These phenomena consistently reflect diminished tubular absorption [8, 231 . Parathyroid hyperactivity has been proposed on several occasions [lo, 26, 34, 43, 451 to account for the hyperphosphaturia; this mechanism should also account for the aminoaciduria. It has been suggested that many of the biochemical and physiological features of the vitamin D deficiency syndrome depend on cellular depletion of the sterol itself [8, 23, 281 . However, the benefit obtained from temporary restoration of extracellular calcium levels by calcium infusion as demonstrated in this study and elsewhere [lo] , indicates that another mechanism for the tubular dysfunction may exist. LAVENDER and PULLMAN [31] have proposed that calcium ion may itself enhance tubular transport of phosphorus; they did not study the effect of this ion on amino acid absorption. However, the suppresive action of calcium upon synthesis and release of parathyroid hormone must also be considered [3 1,361 . Experimental vitamin D deficiency in the mammal is associated with significant parathyroid hyperactivity [2, 3, 11, 20, 32, 35, 37] . Hyperplasia in explants of rat parathyroid glands and hypersecretion of calcium mobilizing hormone occur in uitro in response to diminished calcium concentration in the medium [36] . Hypertrophy and hyperfunction of parathyroid tissue also occur in uiuo in the vitamin Ddeficient rat [3] ; the process is dependent on the hypocalcemia and not on deficiency of vitamin D per se. Tubular dysfunction in thevitaminD-deficient rat can be attributed to a direct effect of parathyroid hormone [2, 20] ; the abnormality in the rat is not dependent on cellular depletion of vitamin D itself, and it is enhanced by exogenous PTE and suppressed by calcium infusion or parathyroidectomy [20] .
One may thus believe by analogy that the tubular dysfunction of vitamin D deficiency in man is indeed parathyroid dependent; however, there arenoteworthy differences between the species in their response to vitamin D deficiency. For instance, the rat, unlike the human and the dog, does not develop marked hypophosphatemia in advanced vitamin D deficiency, which may explain the relative rarity of rickets in the rat exposed to simple vitamin D deficiency [22] . The tubular response also varies in different species; aminoaciduria appears relatively early (stage 11) in the human deficiency syndrome, but only after severe hypocalcemia has been present for several weeks in the rat Hyperparathyroidism as the cause of hyperaminoaciduria a n d phosphaturia in h u m a n . . . 433 [33] , and it apparently never occurs in the hypocalcemic, vitamin D-deficient dog4. The hypothesis could be strengthened if primary hyperparathyroidism in man were known to be accompanied by high renal clearance of amino acids and phosphorus. Documentation of hormone-dependent hyperaminoaciduria is rare in reports on primary hyperparathyroidisni [24, 291 ; others have stated it to be absent [28] . However, a review of the data on 127 patients with primary hyperparathyroidism from the series of DENT [15] revealed that some degree of renal hyperaminoaciduria is present in 44 % of the total group; the incidence is higher (65 %) in those first presenting with bone disease. The hyperaminoaciduria (and hyperphosphaturia) disappears after corrective surgical parathyroidectomy in most patients.
A number of interesting clinical features of the human vitamin D deficiency syndrome merit attention. In thepresent study, asex ratio of2 : 1 in favor of affected males was observed in vitamin D deficiency (table I) . A similar ratio has also been reported by others [7, 33] . The significance of this finding is not clear; there is, of course, at least one X-linked gene which is responsible for renal tubular conservation of phosphorus [49] , but how this predisposes to the manifestation ofvitamin D deficiency in males is unknown.
In severe vitamin D deficiency, PTE may be relatively ineffective in raising the serum calcium level; this was observed in the present study ( fig. 6 ) and also by earlier investigators [28, 45] . The 'pseudohypoparathyroidism' proposed to explain this observation [45] can be reinterpreted as the requirement for vitamin D to mediate the action of PTH on intestinal absorption of calcium and on release of calcium from bone [23, 381 . Severe deficiency of the vitamin blocks the homeostatic effect of PTH; hence the fall in blood calcium levels and the poor response to PTE in raising serum calcium levels [2] . On the other hand, the tubular response to PTE does not require vitamin D [2, 201; hyperaminoaciduria and the anticipated effects on phosphorus metabolism are thus observed following PTE injection in the deficient human infant (fig. 6 ).
The initial stage of the deficiency syndrome is important because of the clinical predilection for tetany or convulsions; its sole biochemical manifestation is hypocalcemia. Roentgen findings are minimal and effectively limited to the skull. Unless this stage of the syndrome, which is found in young infants in the early months of the year, is recognized, the infant will remain at risk until the second stage of deficiency evolves, or until the infant receives vitamin D. One of the most intriguing questions about the human deficiency syn-FRASER, D. ; KOOH, S.W. and PAUNIER, L. : unpublished data. drome concerns the existence at any time of stage I deficiency. Why does hypocalcemia appear and then persist for several days; why is there no immediate effective parathyroid response at this time?
